Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market... Show more
CYAN moved below its 50-day moving average on October 16, 2025 date and that indicates a change from an upward trend to a downward trend. In of 58 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where CYAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on October 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CYAN as a result. In of 110 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CYAN turned negative on October 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYAN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CYAN broke above its upper Bollinger Band on September 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CYAN entered a downward trend on September 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The 10-day moving average for CYAN crossed bullishly above the 50-day moving average on October 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CYAN advanced for three days, in of 192 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CYAN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.263) is normal, around the industry mean (38.906). P/E Ratio (0.000) is within average values for comparable stocks, (31.461). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.817). CYAN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (0.086) is also within normal values, averaging (132.011).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
a developer of natural products
Industry FoodMajorDiversified
A.I.dvisor tells us that CYAN and STKH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYAN and STKH's prices will move in lockstep.
Ticker / NAME | Correlation To CYAN | 1D Price Change % | ||
---|---|---|---|---|
CYAN | 100% | N/A | ||
STKH - CYAN | 24% Poorly correlated | -5.78% | ||
BYND - CYAN | 20% Poorly correlated | +24.15% | ||
LSF - CYAN | 20% Poorly correlated | -4.28% | ||
JBSS - CYAN | 20% Poorly correlated | -0.23% | ||
JVA - CYAN | 20% Poorly correlated | -2.65% | ||
More |
Ticker / NAME | Correlation To CYAN | 1D Price Change % |
---|---|---|
CYAN | 100% | N/A |
Food: Major Diversified industry (197 stocks) | 17% Poorly correlated | +0.12% |
natural industry (10 stocks) | 17% Poorly correlated | +0.00% |
medical service industry (144 stocks) | 14% Poorly correlated | -0.77% |
medical research industry (119 stocks) | 12% Poorly correlated | -0.92% |